James Caldwell, DO
MOHS-Micrographic Surgery · Tallahassee, FLNPI 1639186513
Payments from drug & device makers
Across 83 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$496
- LEO Pharma Inc.$341
- Sanofi$204
- Pfizer$181
- Biofrontera Inc.$138
- Kerecis Limited$103
- plus $327 from 8 others
What the payments were for
- Food & beverage$1,790100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 19 | $496 |
| LEO Pharma Inc. | 17 | $341 |
| Sanofi | 8 | $204 |
| Pfizer | 12 | $181 |
| Biofrontera Inc. | 7 | $138 |
| Kerecis Limited | 2 | $103 |
| Galderma Laboratories, L.p. | 5 | $78 |
| Almirall LLC | 4 | $76 |
| Regeneron Healthcare Solutions, Inc. | 4 | $71 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Taro Pharmaceuticals USA, Inc. | 1 | $15 |
How this compares
$1,790 in reported general payments places this provider in the 45th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 77 | $4,107 |
| Imiquimod | 60 | $2,402 |
| Ketoconazole | 62 | $1,773 |
| Triamcinolone Acetonide | 48 | $1,112 |
| Mupirocin | 53 | $478 |
| Doxycycline Hyclate | 19 | $273 |
| ValacyclovirValacyclovir Hcl | 24 | $195 |
| Minocycline Hcl | 14 | $182 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Tallahassee
- Armand CognettaTallahassee$139K
- Ira FreilichTallahassee$10K
- Eli SaleebyCoral Springs$864K
- Martin ZaiacMiami Beach$593K
- Lilia CorreaTampa$479K
- Andrew WeinsteinBoynton Beach$197K
- Anand HaryaniSebastian$176K
- Paul BenedettoCoral Springs$106K
- Scott FoskoGainesville$105K
- Jeremy SunseriPanama City$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.